# Nucleoside Therapy in Patients With Telomere Biology Disorders

> **NCT06817590** · PHASE1 · RECRUITING · sponsor: **Suneet Agarwal** · enrollment: 36 (estimated)

## Conditions studied

- Telomere Biology Disorders
- Dyskeratosis Congenita
- Revesz Syndrome
- Hoyeraal Hreidarsson Syndrome
- Telomere Biology Disorders With Bone Marrow Failure
- Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)
- Pulmonary Fibrosis, Familial (Telomere Biology Disorder)

## Interventions

- **DRUG:** deoxycytidine
- **DRUG:** deoxythymidine

## Key facts

- **NCT ID:** NCT06817590
- **Lead sponsor:** Suneet Agarwal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-29
- **Primary completion:** 2028-06
- **Final completion:** 2029-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817590, "Nucleoside Therapy in Patients With Telomere Biology Disorders". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06817590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*